Senicapoc

Senicapoc is an inhibitor of intermediate conductance calcium-activated potassium (IKCa1/KCa3.1) channels. It inhibits rubidium efflux from and dehydration of isolated human red blood cells (RBCs) induced by the calcium ionophore A23187 (Cay-11016, IC50s = 11 and 30 nM, respectively). Senicapoc (10 mg/kg twice per day) reduces IKCa1/KCa3.1 channel activity, increases potassium levels in RBCs, and decreases erythrocyte density in the SAD transgenic mouse model of sickle cell disease. It inhibits IL-2, IFN-gamma, IL-12, and IL-17A production in CD3+ T cells stimulated with phorbol 12-myristate 13-acetate (PMA, Cay-10008014) and ionomycin (Cay-10004974, Cay-11932) when used at a concentration of 1 µM. Senicapoc (100 mg/kg) increases the paw withdrawal threshold in a rat model of chronic constriction injury (CCI) of the sciatic nerve.Formal Name: 4-fluoro-alpha-(4-fluorophenyl)-alpha-phenyl-benzeneacetamide. CAS Number: 289656-45-7. Synonyms: ICA-17043. Molecular Formula: C20H15F2NO. Formula Weight: 323.3. Purity: >98%. Formulation: (Request formulation change), A solid. Solubility: DMF: 10 mg/ml, DMF:PBS (pH 7.2) (1:6): 0.14 mg/ml, DMSO: 5 mg/ml, Ethanol: 2 mg/ml. SMILES: O=C(N)C(C1=CC=C(F)C=C1)(C2=CC=C(F)C=C2)C3=CC=CC=C3. InChi Code: InChI=1S/C20H15F2NO/c21-17-10-6-15(7-11-17)20(19(23)24,14-4-2-1-3-5-14)16-8-12-18(22)13-9-16/h1-13H,(H2,23,24). InChi Key: SCTZUZTYRMOMKT-UHFFFAOYSA-N.